Today in Brussels, Amanda’s message ‘Why Science Needs Psychedelics: A Paradigm Shift for Psychiatry’ was presented to the 5th Session of the World Congress for Freedom of Scientific Research. This conference, hosted in the European Parliament, focused on individual rights to benefit from science, and the freedom to perform medical research and receive medical treatment. Psychedelic studies epitomize a field where the ability to exercise these rights is critical – a field in which for decades, scientific progress has been stifled and suppressed restrictive regulations.
As part of her call for a paradigm shift in psychiatry, Amanda outlines concrete action which must be taken by policy-makers to facilitate psychedelic research and therapy.Amanda Feilding_Policy Recommendation SCALED
Psilocybin for Depression
Type of publication